Olanib 150 mg (Olaparib)

Olanib 150 mg (Olaparib)

Manufacturer: Everest Pharmaceuticals Ltd.

Olanib is used for the returning treatment of some types of ovarian cancer in patients who have had platinum chemotherapy or a change in a gene called BRCA. Olanib is a potent oral poly(ADP-ribose) polymerase (PARP) inhibitor. Cancer cells rely on PARP to stay alive, including cancer cells whose BRCA gene changes, thus Olanib works to stop PARP from repairing DNA damage which results in the death of cancer cells.
Brand Name Olanib
Generic Name Olaparib
Packing 112
Form Capsule
Strength 50mg & 150mg
Country Bangladesh


Olanib is used in the treatment of ovarian cancer that has returned after treatment using platinum chemotherapy.

How it Works
Olanib is a potent oral poly(ADP-ribose) polymerase (PARP) inhibitor. PARP is a protein that helps cells repair themselves. By inhibiting the action of PARP cancer cells are unable to repair themselves.

Common Side effects

These side effects may occur in 10% of people

Loss of appetite

Expert advice

It is advisable to contact your doctor and go to the emergency room immediately if you experience a fever of 38 degrees or more with chills, if you have an allergic reaction such as swelling, itching, or hives and if you are experiencing troubles breathing and having uncontrollable cough.

Important Precautions

It is advisable to inform your doctor of any other medications or prescription medications you are taking before starting Olanib treatment. You are also advised against taking any kind of vaccination or immunization while on Olanib treatment.


Store Olanib in a cold dry place away from direct sunlight exposure.

Other Notes

This product is certified and registered with the Directorate General of Drug Administration (DGDA), Ministry of Health & Family Welfare, Government of the People’s republic of Bangladesh.


error: Content is protected !!